Azastene

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Azastene
Azastene.svg
Names
Other names
Win-17625
Identifiers
13074-00-5
3D model (Jmol) Interactive image
ChEMBL ChEMBL2103987
ChemSpider 9900482
PubChem 11725766
Properties
C23H33NO2
Molar mass 355.52 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Azastene, also known as 4,4,17α-trimethylandrosta-2,5-dieno(2,3-d)isoxazol-17β-ol, is a chemical that modulates 3β-hydroxysteroid dehydrogenase activity.[1]

Synthesis[edit]

Azastene synthesis:[2]

One synthesis of this compound involves initial alkylation of methyl testosterone by means of strong base and methyl iodide to afford the 4,4-dimethyl derivative. Formylation with alkoxide and methyl formate leads to the 2-hydroxymethyl derivative. Reaction of this last with hydroxylamine leads to formation of an isoxazole ring. There is then obtained azastene.

References[edit]

  1. ^ Liu, CG; Dai, MZ; Li, WK; Liu, GM; Lin, ZM; Ma, RH (1987). "Interceptive action of azastene and its effects on plasma progesterone in pregnant rats and rabbits". Zhongguo yao li xue bao = Acta pharmacologica Sinica. 8 (6): 540–3. PMID 3451668. 
  2. ^ Gordon O. Potts, Sterling Drug Inc. U.S. Patent 3,966,926 (1976).